Adaptation of human iPSC-derived cardiomyocytes to tyrosine kinase inhibitors reduces acute cardiotoxicity via metabolic reprogramming

Tyrosine kinase inhibitors (TKIs) are widely used to treat solid tumors but can be cardiotoxic. The molecular basis for this toxicity and its relationship to therapeutic mechanisms remain unclear; we therefore undertook a systems-level analysis of human cardiomyocytes exposed to four TKIs. Cardiomyo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Syst
Main Authors: Wang, Huan, Sheehan, Robert P., Palmer, Adam C., Everley, Robert A., Boswell, Sarah A., Ron-Harel, Noga, Ringel, Alison E., Holton, Kristina M., Jacobson, Connor A., Erickson, Alison R., Maliszewski, Laura, Haigis, Marcia C., Sorger, Peter K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6657491/
https://ncbi.nlm.nih.gov/pubmed/31078528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cels.2019.03.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados